ÂÜÀòÂÒÂ×

Mr. Anderson offers over 30 years of senior executive leadership experience in the medical device industry. Mr. Anderson is the founder and Chairman of Revival Healthcare Capital, a sustainable, high impact investment firm that specializes in medical devices and diagnostics. He currently serves on the boards of Apollo Endosurgery (Nasdaq: APEN) and Cardiologs, a leading cardiovascular artificial intelligence company; on the Executive Advisory Board of LEK Consulting, a leading healthcare consulting firm; and as an Independent Director of ConvaTec Group Plc, a FTSE 250 company specializing in medical products and related technologies. Anderson previously served as Chairman of the Board and CEO of ConvaTec Group Plc, where in his one-year interim roles he created additional shareholder value through his "Pivot to Growth" strategy and new $150 million transformation plan. Prior to his time with Revival Healthcare Capital, Mr. Anderson served as the Managing Director of P TV Healthcare Capital. He also served as the Company Group Chairman of Johnson & Johnson and Worldwide Franchise Chairman of Cordis Corporation. Anderson was a key architect behind the launch of the world's first drug-eluting stent, the CYPHER@ Sirolimus- eluting Coronary Stent. Anderson holds a B.B.A. in Marketing from Mississippi State University.